It’s only fair to share… Lirucitinib CAS 2458115-78-9 MF C16H25N5OS MW335.5 g/mol N-[4-[(ethylsulfonimidoyl)methyl]cyclohexyl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (R)-ethyl(imino)({trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}methyl)-λ6-sulfanoneJanus tyrosine kinase inhibitor, anti-inflammatory, GGW101, GGW 101 Lirucitinib is a Janus kinase (JAK) inhibitor primarily known as a novel, Class I veterinary drug. It specifically targets the JAK1 enzyme to block itch-inducing (pruritic) and inflammation-causing cytokines in the body. Core Information SYN …